Among breast cancers, triple-negative breast cancer (TNBC) sub-type is one of the aggressive breast cancers as TNBC cells lack all three currently targetable molecules such as estrogen receptor, progesterone receptor, and HER2. This evidence concerns the gene ERBB2 and breast carcinoma.